Steven S. Williamson net worth and biography

Steven Williamson Biography and Net Worth

Insider of Outset Medical

Steve Williamson joined Outset as Chief Commercial Officer in November 2020, where he is leading the company’s commercial and service organizations. He has over two decades of medical technology industry experience. Prior to joining Outset, he served as the Worldwide President for the Peripheral Intervention (PI) business unit of BD, joining BD as part of the C.R. Bard acquisition in 2017. In the eight years that Steve ran PI, he drove significant revenue growth along with a robust cadence of innovative product launches, numerous acquisitions and global expansion for the End Stage Renal Disease (ESRD), Peripheral Arterial Disease (PAD), and Oncology businesses. Steve joined Bard from Hologic where he was the Senior Vice President and General Manager of the GYN Surgical Products Business.

Steve earned a Bachelor of Business Administration from the University of Massachusetts, Amherst and an MBA from Bentley College.

What is Steven S. Williamson's net worth?: The estimated net worth of Steven S. Williamson is at least $256,851.27 as of August 20th, 2024. Mr. Williamson owns 219,531 shares of Outset Medical stock worth more than $256,851 as of December 30th. This net worth estimate does not reflect any other investments that Mr. Williamson may own. Learn More about Steven S. Williamson's net worth.
How do I contact Steven S. Williamson?: The corporate mailing address for Mr. Williamson and other Outset Medical executives is 3052 ORCHARD DRIVE, SAN JOSE CA, 95134. Outset Medical can also be reached via phone at 669-231-8200 and via email at [email protected]. Learn More on Steven S. Williamson's contact information.
Has Steven S. Williamson been buying or selling shares of Outset Medical?: Steven S. Williamson has not been actively trading shares of Outset Medical within the last three months. Most recently, Steven S. Williamson sold 2,500 shares of the business's stock in a transaction on Thursday, February 15th. The shares were sold at an average price of $3.57, for a transaction totalling $8,925.00. Following the completion of the sale, the insider now directly owns 320,347 shares of the company's stock, valued at $1,143,638.79. Learn More on Steven S. Williamson's trading history.
Who are Outset Medical's active insiders?: Outset Medical's insider roster includes Nabeel Ahmed (VP), John Brottem (General Counsel), Rebecca Chambers (CFO), D. Grossman (Director), James Hinrichs (Director), Leslie Trigg (CEO), Martin Vazquez (COO), and Steven Williamson (Insider). Learn More on Outset Medical's active insiders.
Are insiders buying or selling shares of Outset Medical?: In the last year, insiders at the sold shares 33 times. They sold a total of 165,765 shares worth more than $897,339.88. The most recent insider tranaction occured on November, 15th when CEO Leslie Trigg sold 5,645 shares worth more than $4,516.00. Insiders at Outset Medical own 3.5% of the company. Learn More about insider trades at Outset Medical.
Information on this page was last updated on 11/15/2024.

Steven S. Williamson Insider Trading History at Outset Medical

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/15/2024	Sell	2,500	$3.57	$8,925.00	320,347
1/16/2024	Sell	996	$4.29	$4,272.84	322,847
1/8/2024	Sell	7,055	$5.49	$38,731.95	105,939
5/16/2023	Sell	681	$19.91	$13,558.71	117,212
5/8/2023	Sell	10,000	$19.83	$198,300.00	117,893
1/27/2023	Sell	3,023	$27.92	$84,402.16	127,165
1/25/2022	Sell	2,280	$37.74	$86,047.20

Steven S. Williamson Buying and Selling Activity at Outset Medical

Outset Medical Company Overview

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

Today's Range

Now: $1.17

$1.08

$1.22

50 Day Range

MA: $0.89

$0.53

$1.32

2 Week Range

Now: $1.17

$0.44

$5.88

Volume

527,880 shs

Average Volume

1,269,921 shs

Market Capitalization

$61.47 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.16

Last time you’ll see this priced at $1.00

From StocksToTrade | Ad

When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds for a dollar anymore!

Click here to review Tim’s special Holiday offer before it’s too late.